Pharmacological Inhibition of the Protein Kinase MRK/ZAK Radiosensitizes Medulloblastoma.

Saved in:
Bibliographic Details
Title: Pharmacological Inhibition of the Protein Kinase MRK/ZAK Radiosensitizes Medulloblastoma.
Authors: Markowitz D; Center of Oncology and Cell Biology, Feinstein Institute, Manhasset, New York., Powell C; Center of Oncology and Cell Biology, Feinstein Institute, Manhasset, New York., Tran NL; Translational Genomics Research Institute, Phoenix, Arizona., Berens ME; Translational Genomics Research Institute, Phoenix, Arizona., Ryken TC; Department of Neurosurgery, Kansas University Medical Center, Kansas City, Kansas., Vanan M; Section of Pediatric Hematology/Oncology/BMT, University of Manitoba, Winnipeg, Canada., Rosen L; Biostatistic Unit, Feinstein Institute, Manhasset, New York., He M; Center for Molecular Innovation, Feinstein Institute, Manhasset, New York., Sun S; Center for Molecular Innovation, Feinstein Institute, Manhasset, New York., Symons M; Center of Oncology and Cell Biology, Feinstein Institute, Manhasset, New York. mruggier@northwell.edu msymons@northwell.edu., Al-Abed Y; Center for Molecular Innovation, Feinstein Institute, Manhasset, New York., Ruggieri R; Center of Oncology and Cell Biology, Feinstein Institute, Manhasset, New York. mruggier@northwell.edu msymons@northwell.edu.
Source: Molecular cancer therapeutics [Mol Cancer Ther] 2016 Aug; Vol. 15 (8), pp. 1799-808. Date of Electronic Publication: 2016 May 20.
Publication Type: Journal Article
Journal Info: Publisher: American Association for Cancer Research, Inc Country of Publication: United States NLM ID: 101132535 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1538-8514 (Electronic) Linking ISSN: 15357163 NLM ISO Abbreviation: Mol Cancer Ther Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1538-8514
DOI:10.1158/1535-7163.MCT-15-0849